CompoAtlas

Novexiz GuwaNRG Capsules

Novexiz GuwaNRG Capsules : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL22016108TC
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
AMIPRO SDN. BHD.
Manufacturer
RUZA RESOURCES MANUFACTURING SDN BHD
Registration period starting
2022-01-26
Published validity end
2027-01-26

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Withania somniferaWithania somnifera[60 mg,500 mg]Not identified
Asparagus racemosusAsparagus racemosus[50 mg,500 mg]Not identified
Emblica officinalisEmblica officinalis[25 mg,500 mg]Not identified
Terminalia chebulaTerminalia chebula[25 mg,500 mg]Not identified
Tribulus terrestrisTribulus terrestris[10 mg,500 mg]Not identified
Kaempferia parvifloraKaempferia parviflora[10 mg,500 mg]Not identified
Pueraria tuberosaPueraria tuberosa[10 mg,500 mg]Not identified
Eclipta albaEclipta alba[10 mg,500 mg]Not identified
Piper longumPiper longum[10 mg,500 mg]Not identified
Tinospora cordifoliaTinospora cordifolia[40 mg,500 mg]Not identified
Bacopa monnieriBacopa monnieri[40 mg,500 mg]Not identified
Glycyrrhiza glabraGlycyrrhiza glabra[60 mg,500 mg]Not identified
Cichorium intybusCichorium intybus[20 mg,500 mg]Not identified
Piper nigrumPiper nigrum[2.5 mg,500 mg]Not identified
Vitis viniferaVitis vinifera[100 mg,500 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Withania somnifera[60 mg,500 mg],Asparagus racemosus[50 mg,500 mg],Emblica officinalis[25 mg,500 mg],Terminalia chebula[25 mg,500 mg],Tribulus terrestris[10 mg,500 mg],Kaempferia parviflora[10 mg,500 mg],Pueraria tuberosa[10 mg,500 mg],Eclipta alba[10 mg,500 mg],Piper longum[10 mg,500 mg],Tinospora cordifolia[40 mg,500 mg],Bacopa monnieri[40 mg,500 mg],Glycyrrhiza glabra[60 mg,500 mg],Cichorium intybus[20 mg,500 mg],Piper nigrum[2.5 mg,500 mg],Vitis vinifera[100 mg,500 mg]
Valid until
2027-01-26
Registration date
2022-01-26
Published description
NATURAL PRODUCT
Licence holder
AMIPRO SDN. BHD.
Producer
RUZA RESOURCES MANUFACTURING SDN BHD
Published name
Novexiz GuwaNRG Capsules
Published reference
202106235576T
Registration number
MAL22016108TC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL22016108TC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Withania somnifera
    Read the warning, when it applies and the studies cited

    ASHWAGANDHA - WITHANIA SOMNIFERA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 February 2025

  • Tribulus terrestris
    Read the warning, when it applies and the studies cited

    TRIBULUS - TRIBULUS TERRESTRIS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except Vrsya (aphrodisiac for men).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Chen and Chen 2004).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Traditional Chinese Medicine.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have qi or blood deficiency (Bensky et al. 2004).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have low blood pressure or liver deficiency (Bensky et al. 2004; Chen and Chen 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (Bensky et al. 2004)

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All products except Mutrala (diuretic).

    When using this product diuretic effect may occur.

    Health Canada monograph dated 29 May 2026

  • Glycyrrhiza glabra
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line